Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Nuclear Medicine

Free Subscription Articles published in Semin Nucl Med Retrieve available abstracts of 99 articles: HTML format

Single Articles

June 2025
1. DELGADO BOLTON RC, Calapaqui Teran AK, Santiago Almeida L, Paez D, et al
   Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective.
   Semin Nucl Med. 2025 Jun 1:S0001-2998(25)00060.
   PubMed     Abstract available
   
   
   May 2025
2. MENA E, Lindenberg L, Herscovitch P, Sadowski SM, et al
   Advances in Endocrine Tumor PET Imaging Targeting CXCR4 and GLP-1.
   Semin Nucl Med. 2025 May 29:S0001-2998(25)00058.
   PubMed     Abstract available
   
   
   
3. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
   (18)F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment.
   Semin Nucl Med. 2025 May 29:S0001-2998(25)00057.
   PubMed     Abstract available
   
   
   
4. BENDER D
   New Radiopharmaceutical Tools in Imaging.
   Semin Nucl Med. 2025 May 26:S0001-2998(25)00059.
   PubMed     Abstract available
   
   
   
5. BARANSKA K, Niemas K, Pelka K, Kunikowska J, et al
   PET/CT in the Imaging of CNS Tumors.
   Semin Nucl Med. 2025 May 21:S0001-2998(25)00040.
   PubMed     Abstract available
   
   
   
6. LIN Z, Rasinski P, Nilsson T, Holstensson M, et al
   FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview.
   Semin Nucl Med. 2025 May 20:S0001-2998(25)00056.
   PubMed     Abstract available
   
   
   
7. BRINK A, Paez D, Estrada Lobato E, Delgado Bolton RC, et al
   New Targets for Imaging in Nuclear Medicine.
   Semin Nucl Med. 2025 May 6:S0001-2998(25)00039.
   PubMed     Abstract available
   
   
   
8. NERATTINI M, Abenavoli EM, Berti V
   PET/CT in Movement Disorders: Update.
   Semin Nucl Med. 2025 May 3:S0001-2998(25)00036.
   PubMed     Abstract available
   
   
   
9. CAIRNS J, Frood R, Patel C, Scarsbrook A, et al
   The Role of AI in Lymphoma: An Update.
   Semin Nucl Med. 2025;55:377-386.
   PubMed     Abstract available
   
   
   
10. EJAZ A, Naqvi AH, Perumalla HS, Bateman TM, et al
    Assessment of Myocardial Perfusion in Patients After CABG: An Update and Clinical Implications.
    Semin Nucl Med. 2025;55:460-469.
    PubMed     Abstract available
    
    
    April 2025
11. SPOHN SKB, Grosu AL
    Impact of PSMA PET on Radiation Oncology Planning.
    Semin Nucl Med. 2025 Apr 22:S0001-2998(25)00034.
    PubMed     Abstract available
    
    
    
12. VANDERLINDEN G, Vandenberghe R, Vandenbulcke M, Van Laere K, et al
    The Current Role of Tau PET Imaging in Neurodegeneration.
    Semin Nucl Med. 2025 Apr 21:S0001-2998(25)00031.
    PubMed     Abstract available
    
    
    
13. YANG F, Lei B, Zhou Z, Song TA, et al
    AI in SPECT Imaging: Opportunities and Challenges.
    Semin Nucl Med. 2025 Apr 3:S0001-2998(25)00033.
    PubMed     Abstract available
    
    
    March 2025
14. SAFARIAN A, Mirshahvalad SA, Farbod A, Nasrollahi H, et al
    Artificial intelligence for tumor [(18)F]FDG-PET imaging: Advancement and future trends-part I.
    Semin Nucl Med. 2025 Mar 29:S0001-2998(25)00032.
    PubMed     Abstract available
    
    
    
15. KIRIENKO M, Cavinato L, Sollini M
    Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence.
    Semin Nucl Med. 2025 Mar 21:S0001-2998(25)00021.
    PubMed     Abstract available
    
    
    
16. RICHLITZKI C, Manapov F, Holzgreve A, Rabe M, et al
    Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy.
    Semin Nucl Med. 2025 Mar 9:S0001-2998(25)00022.
    PubMed     Abstract available
    
    
    
17. CANGUT B, Akinlusi R, Mohseny A, Ghesani N, et al
    Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals.
    Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00013.
    PubMed     Abstract available
    
    
    
18. MIKKELSEN AFS, Thygesen J, Fledelius J
    Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine.
    Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00015.
    PubMed     Abstract available
    
    
    
19. SAFARIAN A, Mirshahvalad SA, Nasrollahi H, Jung T, et al
    Impact of [(18)F]FDG PET/CT Radiomics and Artificial Intelligence in Clinical Decision Making in Lung Cancer: Its Current Role.
    Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00014.
    PubMed     Abstract available
    
    
    
20. ALORFI F, Bomanji J, Bertoletti L, Fraioli F, et al
    PET/MRI in Non-Small Cell Lung Cancer (NSCLC).
    Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00019.
    PubMed     Abstract available
    
    
    
21. DELEU AL, Shagera QA, Veldhuijzen van Zanten S, Flamen P, et al
    FAPI PET in the Management of Lung Tumors.
    Semin Nucl Med. 2025 Mar 3:S0001-2998(25)00018.
    PubMed     Abstract available
    
    
    February 2025
22. SATHEKGE C, Maes J, Maes A, Van de Wiele C, et al
    FDG PET/CT for Staging Lung Carcinoma: An Update.
    Semin Nucl Med. 2025 Feb 28:S0001-2998(25)00003.
    PubMed     Abstract available
    
    
    
23. AYENI A, Evbuomwan O, Vangu MW
    The Role of [(18)F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer.
    Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00010.
    PubMed     Abstract available
    
    
    
24. BADARNA M, Keidar Z, Arnon-Sheleg E
    Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma.
    Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00009.
    PubMed     Abstract available
    
    
    
25. VINJAMURI S, Pant V
    Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends.
    Semin Nucl Med. 2025 Feb 26:S0001-2998(25)00011.
    PubMed     Abstract available
    
    
    
26. CURRIE GM, Rohren EM
    Potential of Technetium and Rhenium Theranostics.
    Semin Nucl Med. 2025 Feb 24:S0001-2998(25)00006.
    PubMed     Abstract available
    
    
    
27. LOPES L, Lopez-Montes A, Chen Y, Koller P, et al
    The Evolution of Artificial Intelligence in Nuclear Medicine.
    Semin Nucl Med. 2025 Feb 10:S0001-2998(25)00005.
    PubMed     Abstract available
    
    
    January 2025
28. LIU J, Sandhu K, Woon DTS, Perera M, et al
    The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update.
    Semin Nucl Med. 2025 Jan 31:S0001-2998(24)00120.
    PubMed     Abstract available
    
    
    
29. MOHSENINIA N, Eisazadeh R, Mirshahvalad SA, Zamani-Siahkali N, et al
    Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review.
    Semin Nucl Med. 2025 Jan 23:S0001-2998(25)00001.
    PubMed     Abstract available
    
    
    December 2024
30. SACHPEKIDIS C, Goldschmidt H, Edenbrandt L, Dimitrakopoulou-Strauss A, et al
    Radiomics and Artificial Intelligence Landscape for [(18)F]FDG PET/CT in Multiple Myeloma.
    Semin Nucl Med. 2024 Dec 13:S0001-2998(24)00111.
    PubMed     Abstract available
    
    
    November 2024
31. RATHOD N, Jutidamrongphan W, Bosbach WA, Chen Y, et al
    Total Body PET/CT: Clinical Value and Future Aspects of Quantification in Static and Dynamic Imaging.
    Semin Nucl Med. 2024 Nov 29:S0001-2998(24)00110.
    PubMed     Abstract available
    
    
    
32. ZOGHI S, Mingels C, Badawi RD, Spencer BA, et al
    Role of Total Body PET/CT in Inflammatory Disorders.
    Semin Nucl Med. 2024 Nov 21:S0001-2998(24)00107.
    PubMed     Abstract available
    
    
    
33. HAWK KE, Currie GM
    Artificial Intelligence and Workforce Diversity in Nuclear Medicine.
    Semin Nucl Med. 2024 Nov 19:S0001-2998(24)00090.
    PubMed     Abstract available
    
    
    
34. GERKE O, Naghavi-Behzad M, Nygaard ST, Sigaroudi VR, et al
    Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[(18)F]FDG-PET/CT, (18)F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone Scintigraphy.
    Semin Nucl Med. 2024 Nov 14:S0001-2998(24)00093.
    PubMed     Abstract available
    
    
    
35. DIAS AH, Andersen KF, Fosbol MO, Gormsen LC, et al
    Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging.
    Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00092.
    PubMed     Abstract available
    
    
    
36. GODINEZ F, Mingels C, Bayerlein R, Mehadji B, et al
    Total Body PET/CT: Future Aspects.
    Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00096.
    PubMed     Abstract available
    
    
    
37. MARTINEZ-LUCIO TS, Mendoza-Ibanez OI, Liu W, Mostafapour S, et al
    Long Axial Field of View PET/CT: Technical Aspects in Cardiovascular Diseases.
    Semin Nucl Med. 2024 Nov 12:S0001-2998(24)00094.
    PubMed     Abstract available
    
    
    
38. YANG N, Guo XY, Ding J, Wang F, et al
    Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational.
    Semin Nucl Med. 2024 Nov 8:S0001-2998(24)00086.
    PubMed     Abstract available
    
    
    
39. NANNI C, Farolfi A, Castellucci P, Fanti S, et al
    Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology.
    Semin Nucl Med. 2024 Nov 7:S0001-2998(24)00091.
    PubMed     Abstract available
    
    
    
40. DEV ID, Puranik AD, Singh B, Prasad V, et al
    Current and Future Perspectives of PDL1 PET and SPECT Imaging.
    Semin Nucl Med. 2024 Nov 6:S0001-2998(24)00084.
    PubMed     Abstract available
    
    
    
41. LIN Y, Gao H, Zheng J, Al-Ibraheem A, et al
    Clinical Explorations of [(68)Ga] Ga-FAPI-04 and [(18)F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging.
    Semin Nucl Med. 2024 Nov 2:S0001-2998(24)00085.
    PubMed     Abstract available
    
    
    
42. MENA E, Lindenberg L, Choyke PL
    Update on PSMA-based Prostate Cancer Imaging.
    Semin Nucl Med. 2024;54:941-950.
    PubMed     Abstract available
    
    
    
43. O'BRIEN SR, Edmonds CE, Ward RE, Taunk NK, et al
    Update on (18)F-Fluoroestradiol.
    Semin Nucl Med. 2024;54:812-826.
    PubMed     Abstract available
    
    
    October 2024
44. CUMBERS GA, Harvey-Latham ED, Kassiou M, Werry EL, et al
    Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis.
    Semin Nucl Med. 2024 Oct 29:S0001-2998(24)00082.
    PubMed     Abstract available
    
    
    
45. DUVENHAGE J, Kahts M, Summers B, Zeevaart JR, et al
    Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies.
    Semin Nucl Med. 2024 Oct 26:S0001-2998(24)00088.
    PubMed     Abstract available
    
    
    
46. NOGUEIRA-LIMA E, Alves T, Etchebehere E
    (18)F-Fluoride PET/CT-Updates.
    Semin Nucl Med. 2024 Oct 10:S0001-2998(24)00083.
    PubMed     Abstract available
    
    
    
47. MENG X, Kong X, Wu R, Yang Z, et al
    Total Body PET/CT: A Role in Drug Development?
    Semin Nucl Med. 2024 Oct 9:S0001-2998(24)00081.
    PubMed     Abstract available
    
    
    
48. STORMEZAND GN, de Meyer E, Koopmans KP, Brouwers AH, et al
    Update on the Role of [(18)F]FDOPA PET/CT.
    Semin Nucl Med. 2024 Oct 8:S0001-2998(24)00080.
    PubMed     Abstract available
    
    
    
49. AL-IBRAHEEM A, Abdlkadir AS, Shi H, Abdel-Razeq H, et al
    PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [(68)Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis.
    Semin Nucl Med. 2024 Oct 5:S0001-2998(24)00079.
    PubMed     Abstract available
    
    
    
50. ZHANG Q, Huang Z, Jin Y, Li W, et al
    Total-Body PET/CT: A Role of Artificial Intelligence?
    Semin Nucl Med. 2024 Oct 4:S0001-2998(24)00078.
    PubMed     Abstract available
    
    
    September 2024
51. MINGELS C, Chung KJ, Pantel AR, Rominger A, et al
    Total-Body PET/CT: Challenges and Opportunities.
    Semin Nucl Med. 2024 Sep 27:S0001-2998(24)00076.
    PubMed     Abstract available
    
    
    
52. NOSKOVICOVA L, Balogova S, Aveline C, Tassart M, et al
    (18)F-Fluorocholine-Positron Emission Tomography/Computerized Tomography (FCH PET/CT) Imaging for Detecting Abnormal Parathyroid Glands: Indication, Practice, Interpretation and Diagnostic Performance.
    Semin Nucl Med. 2024 Sep 20:S0001-2998(24)00075.
    PubMed     Abstract available
    
    
    
53. HICKS RJ, Ware RE, Callahan J
    Total-Body PET/CT: Pros and Cons.
    Semin Nucl Med. 2024 Sep 16:S0001-2998(24)00065.
    PubMed     Abstract available
    
    
    
54. NAYFEH M, Sayed A, Alwan M, Alfawara M, et al
    Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging.
    Semin Nucl Med. 2024;54:638-647.
    PubMed     Abstract available
    
    
    
55. CLERC OF, Vijayakumar S, Dorbala S
    Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects.
    Semin Nucl Med. 2024;54:717-732.
    PubMed     Abstract available
    
    
    
56. MILLER RJH, Slomka PJ
    Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends.
    Semin Nucl Med. 2024;54:648-657.
    PubMed     Abstract available
    
    
    August 2024
57. COURAULT P, Zimmer L, Lancelot S
    Toward Functional PET Imaging of the Spinal Cord.
    Semin Nucl Med. 2024 Aug 23:S0001-2998(24)00066.
    PubMed     Abstract available
    
    
    July 2024
58. WAHL RL, Kahl B
    The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?
    Semin Nucl Med. 2024 Jul 16:S0001-2998(24)00055.
    PubMed     Abstract available
    
    
    
59. KLEYNHANS J, Ebenhan T, Sathekge MM
    Expanding Role for Gallium-68 PET Imaging in Oncology.
    Semin Nucl Med. 2024 Jul 3:S0001-2998(24)00054.
    PubMed     Abstract available
    
    
    
60. SATHEKGE MM, Bouchelouche K
    Letter from the Editors.
    Semin Nucl Med. 2024;54:457-459.
    PubMed    
    
    
    June 2024
61. KATAL S, Patel P, Lee J, Taubman K, et al
    Total Body PET/CT: A Role in Musculoskeletal Diseases.
    Semin Nucl Med. 2024 Jun 28:S0001-2998(24)00049.
    PubMed     Abstract available
    
    
    
62. MAHAJAN S, Gavane S, Pandit-Taskar N
    Targeted Radiopharmaceutical Therapy for Bone Metastases.
    Semin Nucl Med. 2024 Jun 26:S0001-2998(24)00047.
    PubMed     Abstract available
    
    
    
63. DULLEA A, O'Sullivan L, O'Brien KK, Carrigan M, et al
    Diagnostic Accuracy of (18)F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews.
    Semin Nucl Med. 2024 Jun 20:S0001-2998(24)00044.
    PubMed     Abstract available
    
    
    
64. KAZIMIERCZYK R, Kaminski KA, Nekolla SG
    Cardiac PET/MRI: Recent Developments and Future Aspects.
    Semin Nucl Med. 2024 Jun 8:S0001-2998(24)00048.
    PubMed     Abstract available
    
    
    
65. DIMITRAKOPOULOU-STRAUSS A, Pan L, Sachpekidis C
    Total Body PET-CT Protocols in Oncology.
    Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00050.
    PubMed     Abstract available
    
    
    
66. CURRIE GM, Hawk KE, Rohren EM
    Generative Artificial Intelligence Biases, Limitations and Risks in Nuclear Medicine: An Argument for Appropriate Use Framework and Recommendations.
    Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00046.
    PubMed     Abstract available
    
    
    
67. SACHPEKIDIS C, Dimitrakopoulou-Strauss A
    Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer.
    Semin Nucl Med. 2024 Jun 1:S0001-2998(24)00045.
    PubMed     Abstract available
    
    
    May 2024
68. BOUCHELOUCHE K, Sathekge MM
    Letter from the Editors.
    Semin Nucl Med. 2024;54:311-312.
    PubMed    
    
    
    
69. HABERL C, Crean AM, Zelt JGE, Redpath CJ, et al
    Role of Nuclear Imaging in Cardiac Stereotactic Body Radiotherapy for Ablation of Ventricular Tachycardia.
    Semin Nucl Med. 2024;54:427-437.
    PubMed     Abstract available
    
    
    April 2024
70. PAEZ D, Giammarile F, Brink A, Garcia-Perez O, et al
    The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis.
    Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00032.
    PubMed     Abstract available
    
    
    
71. GUJA KE, Behr G, Bedmutha A, Kuhn M, et al
    Molecular Imaging with PET-CT and PET-MRI in Pediatric Musculoskeletal Diseases.
    Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00030.
    PubMed     Abstract available
    
    
    March 2024
72. VAN DER GEEST KSM, Gheysens O, Gormsen LC, Glaudemans AWJM, et al
    Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends.
    Semin Nucl Med. 2024 Mar 26:S0001-2998(24)00026.
    PubMed     Abstract available
    
    
    
73. HIGUCHI T, Serfling SE, Leistner DM, Speer T, et al
    FAPI-PET in Cardiovascular Disease.
    Semin Nucl Med. 2024 Mar 21:S0001-2998(24)00023.
    PubMed     Abstract available
    
    
    
74. GUJA KE, Ganjoo KN, Iagaru A
    Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.
    Semin Nucl Med. 2024 Mar 2:S0001-2998(24)00012.
    PubMed     Abstract available
    
    
    
75. EKMEKCIOGLU O, Albert NL, Heinrich K, Tolboom N, et al
    Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques.
    Semin Nucl Med. 2024;54:237-246.
    PubMed     Abstract available
    
    
    
76. EVANGELISTA L, Israel O
    Letter From the Guest Editors.
    Semin Nucl Med. 2024;54:181-182.
    PubMed    
    
    
    
77. FILIPPI L, Camedda R, Frantellizzi V, Urbano N, et al
    Functional Imaging in Musculoskeletal Disorders in Menopause.
    Semin Nucl Med. 2024;54:206-218.
    PubMed     Abstract available
    
    
    February 2024
78. KHALATBARI H, Shulkin BL, Parisi MT
    PET/CT and PET/MR in Soft Tissue Sarcoma: An Update.
    Semin Nucl Med. 2024 Feb 28:S0001-2998(24)00005.
    PubMed     Abstract available
    
    
    
79. ULANER GA, Vaz SC
    Women's Health Update: Growing Role of PET for Patients with Breast Cancer.
    Semin Nucl Med. 2024 Feb 16:S0001-2998(24)00006.
    PubMed     Abstract available
    
    
    
80. GIAMMARILE F, Knoll P, Paez D, Estrada Lobato E, et al
    Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine.
    Semin Nucl Med. 2024 Feb 15:S0001-2998(24)00001.
    PubMed     Abstract available
    
    
    
81. KHESSIB T, Jha P, Davidzon GA, Iagaru A, et al
    Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
    Semin Nucl Med. 2024 Feb 10:S0001-2998(24)00003.
    PubMed     Abstract available
    
    
    
82. EISAZADEH R, Shahbazi-Akbari M, Mirshahvalad SA, Pirich C, et al
    Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers Part II. [(18)F]F-FLT, [(18)F]F-FET, [(11)C]C-MET and Other Less-Commonly Used Radiotracers.
    Semin Nucl Med. 2024 Feb 7:S0001-2998(24)00002.
    PubMed     Abstract available
    
    
    January 2024
83. EVANGELISTA L, Guglielmo P, Pietrzak A, Lazar AM, et al
    The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health.
    Semin Nucl Med. 2024 Jan 12:S0001-2998(23)00105.
    PubMed     Abstract available
    
    
    
84. ZAMANI-SIAHKALI N, Mirshahvalad SA, Farbod A, Divband G, et al
    SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases.
    Semin Nucl Med. 2024 Jan 2:S0001-2998(23)00093.
    PubMed     Abstract available
    
    
    December 2023
85. BENTESTUEN M, Nalliah S, Stolberg MMK, Zacho HD, et al
    How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers.
    Semin Nucl Med. 2023 Dec 4:S0001-2998(23)00092.
    PubMed     Abstract available
    
    
    
86. TELLI T, Desaulniers M, Pyka T, Caobelli F, et al
    What Role Does PET/MRI Play in Musculoskeletal Disorders?
    Semin Nucl Med. 2023 Dec 2:S0001-2998(23)00091.
    PubMed     Abstract available
    
    
    November 2023
87. GHEYSENS O, de Ponfilly MP, Nocturne G, Seror R, et al
    [(18)F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects.
    Semin Nucl Med. 2023 Nov 28:S0001-2998(23)00083.
    PubMed     Abstract available
    
    
    
88. MOKOALA KMG, Ndlovu H, Lawal I, Sathekge MM, et al
    PET/CT and SPECT/CT for Infection in Joints and Bones: An Overview and Future Directions.
    Semin Nucl Med. 2023 Nov 27:S0001-2998(23)00087.
    PubMed     Abstract available
    
    
    
89. BRINK A, Israel O, Nadel H, Arevalo-Pardo M, et al
    Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce.
    Semin Nucl Med. 2023 Nov 18:S0001-2998(23)00086.
    PubMed     Abstract available
    
    
    
90. VOTER AF, Werner RA, Savas H, Gafita A, et al
    A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging.
    Semin Nucl Med. 2023 Nov 16:S0001-2998(23)00088.
    PubMed     Abstract available
    
    
    
91. BESSON FL, Nocturne G, Noel N, Gheysens O, et al
    PET/CT in Inflammatory and Auto-immune Disorders: Focus on Several Key Molecular Concepts, FDG, and Radiolabeled Probe Perspectives.
    Semin Nucl Med. 2023 Nov 14:S0001-2998(23)00084.
    PubMed     Abstract available
    
    
    
92. CARACCIOLO M, Castello A, Lopci E
    PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview.
    Semin Nucl Med. 2023 Nov 9:S0001-2998(23)00082.
    PubMed     Abstract available
    
    
    
93. GIUBBINI R, Paghera B, Dondi M, Estrada Lobato E, et al
    Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain.
    Semin Nucl Med. 2023;53:733-742.
    PubMed     Abstract available
    
    
    
94. LOW CS, Rao N
    Imaging of Gastrointestinal Bleeding: An Update.
    Semin Nucl Med. 2023;53:766-776.
    PubMed     Abstract available
    
    
    
95. SIRAJ QH
    Functional Imaging of Testicular Torsion.
    Semin Nucl Med. 2023;53:797-808.
    PubMed     Abstract available
    
    
    
96. LE ROUX PY, Le Pennec R, Salaun PY, Zuckier LS, et al
    Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices.
    Semin Nucl Med. 2023;53:743-751.
    PubMed     Abstract available
    
    
    
97. JABBARPOUR A, Ghassel S, Lang J, Leung E, et al
    The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review.
    Semin Nucl Med. 2023;53:752-765.
    PubMed     Abstract available
    
    
    
98. LINDENBERG L, Ahlman M, Lin F, Mena E, et al
    Advances in PET Imaging of the CXCR4 Receptor: [(68)Ga]Ga-PentixaFor.
    Semin Nucl Med. 2023 Nov 1:S0001-2998(23)00080.
    PubMed     Abstract available
    
    
    September 2023
99. MIRSHAHVALAD SA, Eisazadeh R, Shahbazi-Akbari M, Pirich C, et al
    Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers.
    Semin Nucl Med. 2023 Sep 24:S0001-2998(23)00073.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.